|
|
|
|
|
|
|
|
|
|
|
|
|
|
Suven secures European product patent
 |
|
| Hyderabads Suven Life Sciences says the European Patent Office (EPO) has granted the Product Patent, EP 1581492 to its clinical candidate SUVN-502 that is valid until June 2023 |
|
 |
|
|
|
HealthLinx to begin marketing of OvPlex in Q3 2008
 |
|
| Melbourne based HealthLinx will begin marketing and distribution of OvPlex (Ovarian cancer diagnostic) in 3rd quarter 2008 with the claim that this is the accurate ovarian cancer diagnostic in the market |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| More |